Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: Background Most pituitary surgery centres prescribe perioperative glucocorticoids to subjects undergoing transsphenoidal pituitary adenomectomy (TSA), despite reports suggesting this may be unnecessary. Evidence‐based guidelines for glucocorticoid use in TSA have recently been published but there are no prospective studies of their utility. Objective To implement and assess a protocol for reduced glucocorticoid replacement for subjects undergoing TSA. Design Prospective and retrospective cohort study in an Australian pituitary surgery centre. Patients and measurements Clinical and biochemical data for 56 TSAs performed for non‐ACTH‐secreting tumours between March 2004 and April 2006 were prospectively collected and compared with data for 47 TSAs performed between October 2001 and November 2003, before implementation of the protocol. In the prospective cohort, a postoperative days 1–3 morning serum cortisol threshold of 250 nmol/l (91 µg/dl) was used to guide long‐term glucocorticoid requirement. Results Implementation of the protocol was associated with significant reductions in dose and duration of glucocorticoid treatment post TSA in 44 ‘low‐risk’ cases (no preoperative glucocorticoid use or evidence of pituitary apoplexy). In two low‐risk cases, long‐term glucocorticoid replacement was required despite postoperative cortisol greater than 250 nmol/l. Following the remaining 42 low‐risk operations, glucocorticoid was not prescribed on hospital discharge on the basis of morning serum cortisol > 250 nmol/l and no clinical evidence of hypocortisolism. None of these 42 cases required glucocorticoid treatment for hypocortisolism following surgery. Short synacthen tests were performed in 35 of these subjects a minimum of 6 months after surgery and were normal. Use of the protocol was not associated with differences in postoperative complications. Conclusions Reduced glucocorticoid replacement in TSA is safe and reduces patient exposure to glucocorticoids and their potential adverse events. The occurrence of hypocortisolism in two low‐risk subjects with serum cortisol > 250 nmol/l highlights the importance of daily clinical assessment when using this protocol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321
Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey, S. R., Guo, C., Robinson, A. M., Price, A., Giles, M. A., Eastell, R., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.780907.x · Cited by 205
Agha, A., Liew, A., Finucane, F., Baker, L., O'Kelly, P., Tormey, W., & Thompson, C. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02035.x · Cited by 45
Rajaratnam, S., Seshadri, M., Chandy, M., & Rajshekhar, V (2003) · British Journal of Neurosurgery · doi:10.1080/02688690310001611233 · Cited by 36
Cited by
Lamprecht, A., Sorbello, J., Jang, C., Torpy, D. J., & Inder, W. J. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0530 · Cited by 52
Tohti, M., Li, J., Zhou, Y., Hu, Y., Yu, Z., & Ma, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119621 · Cited by 49
“Wentworth 2008[21] Prospective Australia 2004– 2006 56 34 (60.”
BackgroundInfluentialManuylova, E., Calvi, L. M., Vates, G. E., Hastings, C., & Shafiq, I. (2015) · Endocrine Practice · doi:10.4158/ep15652.or · Cited by 16
Jia, X., Pendharkar, A. V., Loftus, P., Dodd, R. L., Chu, O., Fraenkel, M., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161256.or · Cited by 12
Selective use of the insulin tolerance test to diagnose hypopituitarism
Sarlos, S., & Inder, W. J. (2013) · Internal Medicine Journal · doi:10.1111/imj.12011 · Cited by 9
Metadata
- Authors
- Wentworth, J. M., Gao, N., Sumithran, K. P., Maartens, N. F., Kaye, A. H., Colman, P. G., & Ebeling, P. R.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2007-07-11
- Volume
- 68
- Issue
- 1
- Pages
- 29-35
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2116624629
- Cited by
- 36
- References
- 4
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary. https://app.cochat.ai/papers/10.1111/j.1365-2265.2007.02995.x
- The paper
- Wentworth, J. M., Gao, N., Sumithran, K. P., Maartens, N. F., Kaye, A. H., Colman, P. G., & Ebeling, P. R. (2008). Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2007.02995.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.